Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome.
about
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndromeTransplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease.Controversies in the treatment of idiopathic membranous nephropathy.Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adultsThe accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis.Treatment of idiopathic membranous nephropathy.Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trialsMembranous nephropathy: Treatment outline and risk stratificationMembranous nephropathy: Pilot study of a novel regimen combining cyclosporine and Rituximab.Management of idiopathic membranous nephropathy.Glomerular diseases: membranous nephropathy--a modern viewOverview of current and alternative therapies for idiopathic membranous nephropathy.Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.What is the role of rituximab in idiopathic membranous nephropathy?Idiopathic membranous nephropathy in patients with diabetes mellitus: a diagnostic and therapeutic quandary!The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.Efficacy of leflunomide combined with prednisone in the treatment of refractory nephrotic syndrome.
P2860
Q24193098-4C99D368-2160-4948-A9A3-0172AF0ED4A0Q33393068-3DAB65B6-FE00-4859-93D7-71499E8EB5E7Q34248343-8DC2D071-F0AD-4AC0-AF70-B4C8218534C6Q34408113-B030DE38-9EAF-4081-AA9F-504D2DA36A49Q34618530-9B451BF4-3674-4438-A9FE-E4D28272CAB2Q36280345-03545A4B-5B87-4EAA-9AD3-3E1981D47863Q36810470-361A5491-9BFF-49CF-B93F-5AE8CC9D3B8EQ36970147-5F8EFC3F-2F6D-462C-AD2B-D73B32783D25Q37475696-755EEDDC-D24F-4586-A4E2-4A1236F3A11AQ37779802-966D4D5D-2370-48F4-B1EA-B75D0FA20E98Q38118221-89E5B53A-6971-40F0-B667-28905D0072FFQ38425865-F504157B-AE9E-4FD9-A880-41454E4322F9Q41229115-F836B576-E902-43B6-8FA8-F0C368CA5C2DQ45351919-62BF20D9-BD5A-40E6-B92B-471DE87F073BQ49186961-1E1E174E-5D96-45CB-B542-80FC0DA79CE0Q50019614-DD15301C-0966-4526-8DAE-2347FF2FA2A6Q51341198-B616E641-BB61-45EC-ACB9-0C562DB44744
P2860
Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Prospective controlled study o ...... pathy with nephrotic syndrome.
@en
Prospective controlled study o ...... pathy with nephrotic syndrome.
@nl
type
label
Prospective controlled study o ...... pathy with nephrotic syndrome.
@en
Prospective controlled study o ...... pathy with nephrotic syndrome.
@nl
prefLabel
Prospective controlled study o ...... pathy with nephrotic syndrome.
@en
Prospective controlled study o ...... pathy with nephrotic syndrome.
@nl
P2093
P2860
P1433
P1476
Prospective controlled study o ...... pathy with nephrotic syndrome.
@en
P2093
Colin So Tang
Jia Qi Qian
Kai Chung Tse
Kar Neng Lai
Kwok Wah Chan
Man Fai Lam
Sydney Cw Tang
Tak Mao Chan
Yiu Wing Ho
P2860
P304
P356
10.1111/J.1440-1797.2007.00822.X
P577
2007-12-01T00:00:00Z